This indicates that PD-1 antibodies may accelerate the severity of lupus by blocking the biological functions of PD-1 signaling, providing new insights into the regulatory pathways of PD-1 in SLE. The gene discussed is PDCD1; the disease is systemic lupus erythematosus.